Active ingredient
Marstacimab
3 finished FDA listings contain Marstacimab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- MARSTACIMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 150 mg/ml · 75 mg/.5ml
- Brand names in FDA listings
- Hympavzi
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2697133
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761369 | PFIZER INC | 2024-10-11 | 3 |
Official labeling on DailyMed
- HYMPAVZI (MARSTACIMAB-HNCQ) INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] · version 7 · 2026-06-23
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.